Teepu Siddique

Teepu Siddique

Auto-generated profile, based on publicly available information

Teepu Siddique

Neuromuscular Disorders Program, Northwestern University, Feinberg School of Medicine, Chicago, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1993 in Nature
Verified
Journal Article
Open access
PDF file
DRDaniel R. Rosen
Daniel R. Rosen
TSTeepu Siddique
Teepu Siddique
DPDavid Patterson
David Patterson
DFDenise A. Figlewicz
Denise A. Figlewicz
PSPeter Sapp
Peter Sapp
RBRobert H. Brown
Robert H. Brown
AMYOTROPHIC lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord1,2. Its cause is unknown and it is uniformly fatal, typically within five years3. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade4,5. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar4,6,7. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8,9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O–2 to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders11, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.

27 February 2009 in Science
Verified
Journal Article
Closed access
PDF file
TKT. J. Kwiatkowski
T. J. Kwiatkowski
DBD. A. Bosco
D. A. Bosco
ALA. L. LeClerc
A. L. LeClerc
ETE. Tamrazian
E. Tamrazian
CVC. R. Vanderburg
C. R. Vanderburg
RBR. H. Brown
R. H. Brown
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma ( FUS/TLS ) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 ( TDP43 ), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.

20 August 1993 in Science
Verified
Journal Article
Closed access
PDF file
HDHan-Xiang Deng
Han-Xiang Deng
AHAfif Hentati
Afif Hentati
JTjohn Tainer
john Tainer
ZIZafar Iqbal
Zafar Iqbal
ACAnnarueber Cayabyab
Annarueber Cayabyab
AEAl. Et
Al. Et
Single-site mutants in the Cu,Zn superoxide dismutase (SOD) gene ( SOD1 ) occur in patients with the fatal neurodegenerative disorder familial amyotrophic lateral sclerosis (FALS). Complete screening of the SOD1 coding region revealed that the mutation Ala 4 to Val in exon 1 was the most frequent one; mutations were identified in exons 2, 4, and 5 but not in the active site region formed by exon 3. The 2.4 Å crystal structure of human SOD, along with two other SOD structures, established that all 12 observed FALS mutant sites alter conserved interactions critical to the β-barrel fold and dimer contact, rather than catalysis. Red cells from heterozygotes had less than 50 percent normal SOD activity, consistent with a structurally defective SOD dimer. Thus, defective SOD is linked to motor neuron death and carries implications for understanding and possible treatment of FALS.

21 August 2011 in Nature
Verified
Journal Article
Open access
PDF file
HDHan-Xiang Deng
Han-Xiang Deng
WCWenjie Chen
Wenjie Chen
SHSeong-Tshool Hong
Seong-Tshool Hong
KBKym M. Boycott
Kym M. Boycott
GGGeorge H. Gorrie
George H. Gorrie
TSTeepu Siddique
Teepu Siddique
A study of a five-generation family with the usually fatal disorder amyotrophic lateral sclerosis (ALS) has identified mutations in the UBQLN2 gene, which encodes the ubiquitin-like protein ubiquilin 2, as a cause of ALS and ALS/dementia. This finding is of particular interest as it links familial and sporadic forms of the disease through a ubiquilin 2 pathology observed in the spinal cords of ALS cases and in the brains of ALS/dementia cases with or without UBQLN2 mutations. This novel pathology shows that abnormalities in ubiquilin 2 are associated with defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that might be a target for therapeutic intervention. Amyotrophic lateral sclerosis (ALS) is a paralytic and usually fatal disorder caused by motor-neuron degeneration in the brain and spinal cord. Most cases of ALS are sporadic but about 5–10% are familial. Mutations in superoxide dismutase 1 (SOD1)1,2, TAR DNA-binding protein (TARDBP, also known as TDP43)3,4 and fused in sarcoma (FUS, also known as translocated in liposarcoma (TLS))5,6 account for approximately 30% of classic familial ALS. Mutations in several other genes have also been reported as rare causes of ALS or ALS-like syndromes7,8,9,10,11,12,13,14,15. The causes of the remaining cases of familial ALS and of the vast majority of sporadic ALS are unknown. Despite extensive studies of previously identified ALS-causing genes, the pathogenic mechanism underlying motor-neuron degeneration in ALS remains largely obscure. Dementia, usually of the frontotemporal lobar type, may occur in some ALS cases. It is unclear whether ALS and dementia share common aetiology and pathogenesis in ALS/dementia. Here we show that mutations in UBQLN2, which encodes the ubiquitin-like protein ubiquilin 2, cause dominantly inherited, chromosome-X-linked ALS and ALS/dementia. We describe novel ubiquilin 2 pathology in the spinal cords of ALS cases and in the brains of ALS/dementia cases with or without UBQLN2 mutations. Ubiquilin 2 is a member of the ubiquilin family, which regulates the degradation of ubiquitinated proteins. Functional analysis showed that mutations in UBQLN2 lead to an impairment of protein degradation. Therefore, our findings link abnormalities in ubiquilin 2 to defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that can be exploited for therapeutic intervention.

27 April 2007 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
IMIan R. A. Mackenzie
Ian R. A. Mackenzie
EBEileen H. Bigio
Eileen H. Bigio
PIPaul G. Ince
Paul G. Ince
FGFelix Geser
Felix Geser
MNManuela Neumann
Manuela Neumann
JTJohn Q. Trojanowski
John Q. Trojanowski
Objective: Amyotrophic lateral sclerosis (ALS) is a common, fatal motor neuron disorder with no effective treatment. Approximately 10% of cases are familial ALS (FALS), and the most common genetic abnormality is superoxide dismutase‐1 (SOD1) mutations. Most ALS research in the past decade has focused on the neurotoxicity of mutant SOD1, and this knowledge has directed therapeutic strategies. We recently identified TDP‐43 as the major pathological protein in sporadic ALS. In this study, we investigated TDP‐43 in a larger series of ALS cases (n = 111), including familial cases with and without SOD1 mutations.Methods: Ubiquitin and TDP‐43 immunohistochemistry was performed on postmortem tissue from sporadic ALS (n = 59), ALS with SOD1 mutations (n = 15), SOD‐1–negative FALS (n = 11), and ALS with dementia (n = 26). Biochemical analysis was performed on representative cases from each group.Results: All cases of sporadic ALS, ALS with dementia, and SOD1‐negative FALS had neuronal and glial inclusions that were immunoreactive for both ubiquitin and TDP‐43. Cases with SOD1 mutations had ubiquitin‐positive neuronal inclusions; however, no cases were immunoreactive for TDP‐43. Biochemical analysis of postmortem tissue from sporadic ALS and SOD1‐negative FALS demonstrated pathological forms of TDP‐43 that were absent in cases with SOD1 mutations.Interpretation: These findings implicate pathological TDP‐43 in the pathogenesis of sporadic ALS. In contrast, the absence of pathological TDP‐43 in cases with SOD1 mutations implies that motor neuron degeneration in these cases may result from a different mechanism, and that cases with SOD1 mutations may not be the familial counterpart of sporadic ALS. Ann Neurol 2007;61:427–434

1 November 2011 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
FFFaisal Fecto
Faisal Fecto
JYJianhua Yan
Jianhua Yan
SVS. Pavan Vemula
S. Pavan Vemula
ELErdong Liu
Erdong Liu
YYYi Yang
Yi Yang
TSTeepu Siddique
Teepu Siddique
Amyotrophic lateral sclerosis (ALS) is a fatal paralytic disorder caused by degeneration of motor neurons in the brain and spinal cord. About 90% of ALS is sporadic (SALS) with unknown cause. Familial ALS (FALS) is genetically heterogeneous and represents approximately 5% to 10% of ALS cases. The penetrance of genetic mutation–linked FALS may vary substantially, ranging from classic mendelian pattern to apparently sporadic disease. Mutations in the copper-zinc superoxide dismutase gene (SOD1) account for approximately 20% of FALS cases and 1% of SALS cases and represent the most prevalent known cause of ALS.1,2 Several other genes, including TARDBP, FUS, OPTN, and VCP, have recently been linked to ALS.3-9